Relationship between monoclonal gammopathy and cardiac amyloid type.

[1]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[2]  J. Oh,et al.  Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation. , 2011, JACC. Cardiovascular imaging.

[3]  H. R. Bergen,et al.  Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue. , 2011, Archives of neurology.

[4]  Daniel Jones.  Modifying protein misfolding , 2010, Nature Reviews Drug Discovery.

[5]  A. Dispenzieri,et al.  Erratum: Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: A retrospective population-based cohort study (Lancet (2010) 375 (1721-1728)) , 2010 .

[6]  F. Salvi,et al.  Transthyretin-related amyloidoses and the heart: a clinical overview , 2010, Nature Reviews Cardiology.

[7]  M. Gertz,et al.  Pitfalls in the diagnosis of primary amyloidosis. , 2010, Clinical lymphoma, myeloma & leukemia.

[8]  T. Therneau,et al.  Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study , 2010, The Lancet.

[9]  P. Schnabel,et al.  Amyloid in endomyocardial biopsies , 2010, Virchows Archiv.

[10]  H. R. Bergen,et al.  Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. , 2009, Blood.

[11]  L. Hebert,et al.  Typing of amyloidosis in renal biopsies: diagnostic pitfalls. , 2009, Archives of pathology & laboratory medicine.

[12]  J. Stone,et al.  Classification of amyloid deposits in diagnostic cardiac specimens by immunofluorescence. , 2009, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[13]  H. R. Bergen,et al.  Immunoglobulin derived depositions in the nervous system: novel mass spectrometry application for protein characterization in formalin-fixed tissues , 2008, Laboratory Investigation.

[14]  S. Litovsky,et al.  Histomorphometric analysis of intramyocardial vessels in primary and senile amyloidosis: epicardium versus endocardium. , 2008, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[15]  M. Picken,et al.  The burden of "sticky" amyloid: typing challenges. , 2007, Archives of pathology & laboratory medicine.

[16]  Keyur B Shah,et al.  Amyloidosis and the heart: a comprehensive review. , 2006, Archives of internal medicine.

[17]  J. Teruya-Feldstein,et al.  Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins. , 2006, Blood.

[18]  A. Dispenzieri,et al.  Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. , 2005, Clinical chemistry.

[19]  P. Poole‐Wilson,et al.  Cardiovascular Magnetic Resonance in Cardiac Amyloidosis , 2005, Circulation.

[20]  R. Falk,et al.  Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis , 2005, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[21]  T. Therneau,et al.  Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  D. Booth,et al.  Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. , 2002, The New England journal of medicine.

[23]  J. Buxbaum,et al.  Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. , 1997, The New England journal of medicine.

[24]  E. Arbustini,et al.  Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients. , 1995, American heart journal.

[25]  M. Benson.  Hereditary amyloidosis and cardiomyopathy. , 1992, The American journal of medicine.

[26]  E. Calkins,et al.  Amyloid in the Aged Heart: Frequency and Clinical Significance , 1975, Journal of the American Geriatrics Society.

[27]  William T. Abraham,et al.  Focused Update : ACCF / AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults , 2013 .

[28]  W. Edwards,et al.  Amyloidosis and endomyocardial biopsy: Correlation of extent and pattern of deposition with amyloid immunophenotype in 100 cases. , 1995, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[29]  R. Kyle,et al.  Primary systemic amyloidosis: clinical and laboratory features in 474 cases. , 1995, Seminars in hematology.